EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PRAX: Praxis Precision Medicines Inc

03 Nov 25 15:59
LAST:

181.8

CHANGE:
 16.77		OPEN:
196.1		HIGH:
198.8		ASK:
0.0		VOLUME:
940.3K
CHG(%):
8.44		PREV:
198.8		LOW:
167.0		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Nov 25180.5186.7167.0182.01.74M
31 Oct 25198.2202.0195.5198.8375.7K
30 Oct 25191.4206.7191.4201.0535.0K
29 Oct 25198.3198.3191.7195.8631.2K
28 Oct 25183.5200.0182.0199.3840.9K
27 Oct 25174.6187.7174.6185.9898.8K
24 Oct 25180.9181.0168.2174.0526.7K
23 Oct 25185.0187.4177.5178.0643.4K
22 Oct 25189.7193.0178.0184.4612.5K
21 Oct 25178.9191.9176.6190.01.67M

COMPANY PROFILE

Name:Praxis Precision Medicines Inc
About:Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:99 High Street, Boston, MA, United States, 02110
Website:https://praxismedicines.com
CUSIP:74006W108
CIK:0001689548
ISIN:US74006W2070
FIGI:BBG00W9LF2G5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:195.377.5%
MA10:188.923.9%
MA20:139.6830.2%
MA50:83.80117.0%
MA100:66.28174.3%
MA200:57.14218.2%
STO9:24.50
STO14:83.45 
RSI14:77.36 
WPR14:-13.23 
MTM14:124.64
ROC14:2.17 
ATR:26.25 
Week High:206.7113.7%
Week Low:167.038.9%
Month High:206.7113.7%
Month Low:50.31218.2%
Year High:206.7113.7%
Year Low:26.70580.9%
Volatility:11.77 

RECENT SPLITS

Date Ratio
29 Nov 20231-15